In one study, the mean serum NCAM levels were higher in demyelinating neuropathies (both inflammatory and Charcot-Marie-Tooth disease (CMT) type 1A) than in healthy controls and axonal neuropathies, and there was a positive correlation with the Overall Neuropathy Limitations Score [8]. This evidence concerns the gene NCAM1 and Charcot-Marie-Tooth disease.